Li Sheng Pharmaceuticals: Central Pharmaceutical Industry Received 304 Million Yuan Cash Dividend

Lifesheng Pharmaceuticals announced that its wholly-owned subsidiary, Central Pharmaceuticals, holds a 12.15% stake in Tian Shili Biological and will receive a cash dividend of 304 million yuan. This dividend will be included in the company's investment income for the year 2025, positively impacting the company's operating performance. The specific impact amount will be subject to the audited data of the accounting firm.